Your session is about to expire
← Back to Search
Behavioural Intervention
Smartphone Program for Smoking Cessation
N/A
Waitlist Available
Led By Jennifer Marler, MD
Research Sponsored by Pivot Health Technologies Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Current use of ≥1 reduced risk smoke-free nicotine product (e.g., e-cigarettes/vaping, oral nicotine pouch, heat-not-burn)
Aged between 21-65 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4, 8, 12 and 26 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will involve 120 adult smokers who have tried to quit before but couldn't. They will be using the Pivot cigarette smoking cessation program along with other nicotine products to help them quit smoking cigarettes.
Who is the study for?
This trial is for adult smokers who have tried and failed to quit before, and are currently using other smoke-free nicotine products. They should be interested in quitting cigarettes by switching to these alternative products.
What is being tested?
The study is testing the Pivot smoking cessation program, which aims to help participants quit cigarette smoking through a smartphone-based switch program. Up to 120 people will join this open label, single center study.
What are the potential side effects?
Since this trial involves a behavioral intervention rather than medication, there may not be direct side effects like with drugs; however, participants might experience withdrawal symptoms or stress related to quitting smoking.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I currently use at least one smoke-free nicotine product.
Select...
I am between 21 and 65 years old.
Select...
I smoke 5 or more cigarettes daily.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion of participants who completely switch from cigarettes to a smoke-free nicotine product by 12 weeks
Secondary study objectives
Attempts to Quit Nicotine Products
Attempts to Switch
Average % CPD Reduction
+39 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Pivot cigarette smoking cessation programExperimental Treatment1 Intervention
A commercially available mobile phone app and program for smoking cessation
Find a Location
Who is running the clinical trial?
Pivot Health Technologies Inc.Lead Sponsor
3 Previous Clinical Trials
392 Total Patients Enrolled
Jennifer Marler, MDPrincipal InvestigatorPivot Health Technologies Inc.
4 Previous Clinical Trials
276 Total Patients Enrolled